Search

Search Results

1. Sirtuins and Cellular Senescence in Patients with Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Disorders

   The sirtuin family is a heterogeneous group of proteins that play a critical role in many cellular activities. Several degenerative diseases have...

   Vito D’Agnano, Domenica Francesca Mariniello, ... Fabio Perrotta in Drugs

   Article Open access 17 April 2024
   

2. Current state of signaling pathways associated with the pathogenesis of idiopathic pulmonary fibrosis

   Idiopathic Pulmonary Fibrosis (IPF) represents a chronic and progressive pulmonary disorder distinguished by a notable mortality rate. Despite the...

   Yang Zhou, Tingting Ling, Weihong Shi in Respiratory Research

   Article Open access 17 June 2024

3. Assessment of lung deformation in patients with idiopathic pulmonary fibrosis with elastic registration technique on pulmonary three-dimensional ultrashort echo time MRI

   Objective

   To assess lung deformation in patients with idiopathic pulmonary fibrosis (IPF) using with elastic registration algorithm applied to...

   ** Dai in Insights into Imaging

   Article Open access 23 January 2024
   

4. Acute exacerbation of idiopathic pulmonary fibrosis disease: a diagnosis model in China

   Objective

   To develop and validate a diagnosis model to inform risk stratified decisions for idiopathic pulmonary fibrosis patients experiencing acute...

   Liye Meng, Jun **ao, ... Zhuochun Huang in European Journal of Medical Research

   Article Open access 25 March 2024
   

5. Circular RNAs and their roles in idiopathic pulmonary fibrosis

   Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease with limited treatment options. Circular RNAs (circRNAs) have emerged as...

   Akshaya Surendran, Chaoqun Huang, Lin Liu in Respiratory Research

   Article Open access 06 February 2024
   

6. Radiological findings based comparison of functional status in patients who have post-covid lung injury or idiopathic pulmonary fibrosis

   Background

   Following COVID-19 infection, some patients acquired lung injury and fibrosis. Idiopathic pulmonary fibrosis is characterized by lung...

   Deniz Kızılırmak, Seçil Sarı, ... Yavuz Havlucu in BMC Pulmonary Medicine

   Article Open access 30 June 2023
   

7. Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis

   Idiopathic pulmonary fibrosis (IPF) remains a disease with poor survival. The pathogenesis is complex and encompasses multiple molecular pathways....

   Francesco Bonella, Paolo Spagnolo, Chris Ryerson in Drugs

   Article Open access 26 October 2023

8. Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study

   Background

   Our study examined whether prevalent and incident comorbidities are increased in idiopathic pulmonary fibrosis (IPF) patients when compared...

   Burcu Ozaltin, Robert Chapman, ... Joseph Jacob in Respiratory Research

   Article Open access 19 June 2024
   

9. Deep learning-based prognostication in idiopathic pulmonary fibrosis using chest radiographs

   Objectives

   To develop and validate a deep learning-based prognostic model in patients with idiopathic pulmonary fibrosis (IPF) using chest radiographs.

   ...

   Taehee Lee, Su Yeon Ahn, ... Ju Gang Nam in European Radiology

   Article 19 December 2023
   

10. Identification of non-coding RNA signatures in idiopathic pulmonary fibrosis

    Background

    Idiopathic pulmonary fibrosis (IPF) is a deadly, chronic, progressive, irreversible interstitial lung disease characterized by the...

    Alperen Elek, Esra Bozgeyik, ... Ibrahim Bozgeyik in Irish Journal of Medical Science (1971 -)

    Article 25 March 2024
    

11. Initial results with [¹⁸F]FAPI-74 PET/CT in idiopathic pulmonary fibrosis

    Abstract

    Idiopathic pulmonary fibrosis (IPF) is a chronic fibrosing interstitial lung disease with a poor prognosis. ⁶⁸ Ga-labeled FAP ligands...

    Yuriko Mori, Vasko Kramer, ... Álvaro Undurraga in European Journal of Nuclear Medicine and Molecular Imaging

    Article Open access 20 December 2023
    

12. Biomarkers of cellular senescence in idiopathic pulmonary fibrosis

    Background

    Cellular senescence is a cell fate in response to diverse forms of age-related damage and stress that has been implicated in the...

    Zaira Aversa, Elizabeth J. Atkinson, ... Nathan K. LeBrasseur in Respiratory Research

    Article Open access 07 April 2023
    

13. Cardiovascular Structural and Functional Parameters in Idiopathic Pulmonary Fibrosis at Disease Diagnosis

    Introduction

    Prevalence of cardiac and vascular fibrosis in patients with Idiopathic Pulmonary Fibrosis (IPF) has not been extensively evaluated.

    ...

    Paola Faverio, Alessandro Maloberti, ... Cristina Giannattasio in High Blood Pressure & Cardiovascular Prevention

    Article Open access 13 May 2024
    

14. Systematic review of overlap** microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis

    Background

    Pulmonary fibrosis is an emerging complication of SARS-CoV-2 infection. In this study, we speculate that patients with COVID-19 and...

    Julien Guiot, Monique Henket, ... Makon-Sébastien Njock in Respiratory Research

    Article Open access 15 April 2023
    

15. A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema

    Background

    No single pulmonary function test captures the functional effect of emphysema in idiopathic pulmonary fibrosis (IPF). Without experienced...

    Athol U. Wells, Joseph Jacob, ... Vincent Cottin in Respiratory Research

    Article Open access 18 January 2024
    

16. Prognostic value of deep learning–based fibrosis quantification on chest CT in idiopathic pulmonary fibrosis

    Objective

    To investigate the prognostic value of deep learning (DL)–driven CT fibrosis quantification in idiopathic pulmonary fibrosis (IPF).

    ...

    Ju Gang Nam, Yunhee Choi, ... Hyung** Kim in European Radiology

    Article 16 March 2023
    

17. Safety and efficacy of CT-guided percutaneous microwave ablation for stage I non-small cell lung cancer in patients with comorbid idiopathic pulmonary fibrosis

    Objectives

    To evaluate the safety and efficacy of microwave ablation (MWA) for stage I non-small cell lung cancer (NSCLC) in patients with idiopathic...

    **Zhao Peng, Zhi**n Bie, ... **aoGuang Li in European Radiology

    Article 20 December 2023
    

18. Assessment and Management of Cough in Idiopathic Pulmonary Fibrosis: A Narrative Review

    Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fatal disease with an unknown cause. It is characterized by symptoms such as cough...

    Shangxiang Liu, Xu Ye in Lung

    Article 07 November 2023
    

19. Diabetes mellitus and idiopathic pulmonary fibrosis: a Mendelian randomization study

    Background

    The question as to whether or not diabetes mellitus increases the risk of idiopathic pulmonary fibrosis (IPF) remains controversial. This...

    Quou Kang, **g Ren, ... Wencheng Yu in BMC Pulmonary Medicine

    Article Open access 20 March 2024
    

20. MMP19 Variants in Familial and Sporadic Idiopathic Pulmonary Fibrosis

    Background

    Gene variants have been identified in patients with familial or sporadic idiopathic pulmonary fibrosis (IPF). These variants may partially...

    Yali Fan, Chunming Zheng, ... Qiao Ye in Lung

    Article 16 November 2023